TISSUE REGENIX GROUP PLC
Develops regenerative biological products for orthopaedic and dental markets.
TRX | IL
Overview
Corporate Details
- ISIN(s):
- GB00BNTXR104
- LEI:
- 213800PNOD5UHQUFJI36
- Country:
- United Kingdom
- Address:
- Unit 3, Phoenix Court Lotherton Way, LS25 2GY Leeds
- Website:
- https://www.tissueregenix.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of medical and dental instruments and supplies
Description
Tissue Regenix Group is a pioneering international medical technology company specializing in regenerative medicine. The company develops and commercializes innovative biological products designed to restore patient function and vitality. Its business is centered on two proprietary platform technologies: dCELL®, a decellularization process that removes cellular material from biological tissues to create a natural scaffold for regeneration, and BioRinse™, a complementary sterilization process for bone and soft tissue. These technologies are applied to create products for key clinical markets, including orthopaedics and dental, with the goal of providing differentiated clinical outcomes and favorable health economic benefits.
This is a Fraction of the Available Data.
You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for TISSUE REGENIX GROUP PLC and 9,000+ other companies.
Stop analyzing yesterday's news. Start building a real-time advantage.
Request Enterprise API AccessFilings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-09-17 08:00 |
Report Publication Announcement
Notice of Results
|
English | 11.5 KB | |
| 2025-09-08 08:01 |
Earnings Release
Half-Year Trading Update and Notice of Results
|
English | 14.3 KB | |
| 2025-09-08 08:00 |
Board/Management Information
Board Changes
|
English | 18.7 KB | |
| 2025-08-01 08:00 |
Board/Management Information
Directorate Change
|
English | 12.1 KB | |
| 2025-07-23 14:52 |
Declaration of Voting Results & Voting Rights Announcements
Result of AGM
|
English | 24.8 KB | |
| 2025-07-04 08:00 |
Remuneration Information
Grant of share options
|
English | 30.4 KB | |
| 2025-06-27 08:00 |
Report Publication Announcement
Posting of Annual Report & Notice of AGM
|
English | 13.6 KB | |
| 2025-06-25 08:00 |
Investor Presentation
Final results for the year ended 31 December 2024
|
English | 675.5 KB | |
| 2025-03-27 08:00 |
Regulatory News Service
European patent granted
|
English | 12.5 KB | |
| 2025-03-18 08:00 |
Regulatory News Service
Company update
|
English | 11.5 KB | |
| 2025-01-30 08:00 |
Earnings Release
Full year trading update
|
English | 11.9 KB | |
| 2025-01-15 14:25 |
Major Shareholding Notification
Holding(s) in Company
|
English | 22.6 KB | |
| 2025-01-13 15:20 |
Major Shareholding Notification
Holding(s) in Company
|
English | 52.7 KB | |
| 2024-12-09 15:44 |
Major Shareholding Notification
Holding(s) in Company
|
English | 53.1 KB | |
| 2024-11-26 08:00 |
Regulatory News Service
Extended distribution agreement with Arthrex, Inc.
|
English | 9.2 KB |
Automate Your Workflow. Get a real-time feed of all TISSUE REGENIX GROUP PLC filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for TISSUE REGENIX GROUP PLC via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
